Income statement
EUR
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 599M | 600M | 482M | 446M | 408M |
| Gross Profit | 222M | 226M | 182M | 152M | 144M |
| Operating Income | 66M | 61M | 47M | 32M | 37M |
| EBITDA | 87M | 82M | 67M | 47M | 52M |
| Net Income | 53M | 46M | 39M | 45M | 40M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Defensive
Live Price
Offline$16.25
+0.00% today
1Y Change
+16.57%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Gr. Sarantis S.A. (SRTSF) is a Consumer Defensive stock with a market cap of $910.00M and listed on OTC. The stock last traded around $16.25 and up 16.6% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -0.1%, EPS growth of +16.9%, a dividend yield of 0.0%. What stands out right now is revenue -0.1%, EPS +16.9%, free cash flow -8.4% with operating margin 11.0% and ROIC 10.8%. Valuation is more restrained than many high-expectation growth names at P/E 17.1 and price/sales 1.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRTSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SRTSF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SRTSF Max Drawdown
-7.78%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SRTSF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$408.2M
-8.6% YoY
FY Net Income
$40.3M
-11.3% YoY
Free Cash Flow
$20.0M
+69.1% YoY
Revenue Growth
-0.1%
EPS Growth
+16.9%
Gross Margin
37.1%
Net Margin
8.8%
Income statement
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 599M | 600M | 482M | 446M | 408M |
| Gross Profit | 222M | 226M | 182M | 152M | 144M |
| Operating Income | 66M | 61M | 47M | 32M | 37M |
| EBITDA | 87M | 82M | 67M | 47M | 52M |
| Net Income | 53M | 46M | 39M | 45M | 40M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 63M | 47M | 111M | 61M | 46M |
| Total Assets | 633M | 600M | 554M | 500M | 463M |
| Total Liabilities | 232M | 225M | 200M | 169M | 163M |
| Shareholder Equity | 401M | 375M | 354M | 329M | 298M |
| Total Debt | 62M | 84M | 89M | 65M | 68M |
| Net Debt | -573K | 36M | -22M | 4M | 23M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
50M
+121.6% YoY
Capital Expenditures
31M
-178.0% YoY
Free Cash Flow
20M
+69.1% YoY
Key ratios
Gross Margin
37.1%
Operating Margin
11.0%
Net Margin
8.8%
ROE
13.6%
Debt / Equity
0.15x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.